Multidrug resistance genotypes (Insertions in the β3-β4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations

Virology

Volumn 270, Issue 2, 2000, Pages 310-316

  Tamalet, Catherine ^a   Yahi, Nouara ^a   Tourrès, Christian ^a   Colson, Philippe ^a   Quinson, Anne Marie ^a   Poizot Martin, Isabelle ^a   Dhiver, Catherine ^a   Fantini, Jacques ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; POL PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STRAIN DIFFERENCE; VIRUS GENE; VIRUS MUTANT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034630898     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0261     Document Type: Article

References (25)

1. Arion D., Borkow G., Gu Z., Wainberg M. A., Parniak M. A. The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase. J. Biol. Chem. 271:1996;19860-19864.
2. Arion D., Kaushik N., McCormick S., Borkow G., Parniak M. A. Phenotypci mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry. 37:1998;15908-15917.
3. Arnold E., Ding J., Hughes S. H., Hostomsky Z. Structures of DNA and RNA polymerases and their interactions with nucleic acid substrates. Curr. Opin. Struct. Biol. 5:1995;27-38.
4. Boyer P. L., Lisziewicz J., Lori F., Hughes S. H. Analysis of amino insertion mutations in the fingers subdomain of HIV-1 reverse transcriptase. J. Mol. Biol. 286:1999;995-1008.
5. De Jong J. J., Goudsmit J., Lukashov V., Hillebrand M. E., Baan E., Huismans R., Danner S. A., Ten Veen J. H., De Wolf F., Juriaans S. Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. AIDS. 13:1999;75-80.
6. Hirsch M. S., Conway B., D'Aquila R. T., Johnson V. A., Brun-Vezinet F., Clotet B., Demeter L. M., Hammer S. M., Jacobsen D. M., Kuritzkes D. R., Loveday C., Mellors J. W., Vella S., Richman D. D. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. International AIDS Society-USA Panel. J. Am. Med. Assoc. 279:1998;1984-1991.
7. Huang H., Chopra R., Verdine G. L., Harrison S. C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance. Science. 282:1998;1669-1675.
8. Iversen A. K. N., Shafer R. W., Wehrly K., Winters M. A., Mullins J. I., Chesebro B., Merigan T. C. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 70:1996;1086-1090.
9. Jacobo-Molina A., Ding J., Nanni R. G., Clark A. D. Jr., Lu X., Tantillo C., Williams R. L., Kamer G., Ferris A. L., Clark P. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA. 90:1993;6320-6324.
10. Kew Y., Olsen L. R., Japour A. J., Prasad V. R. Insertions into the β3-β4 hairpin loop of HIV-1 reverse transcriptase reveal a role for fingers subdomain in processive polymerization. J. Biol. Chem. 273:1998;7529-7537.
11. Koch N., Yahi N., Colson P., Fantini J., Tamalet C. Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis. J. Virol. Methods. 80:1999;25-31.
12. Kohlstaedt L. A., Wang J., Friedman J. M., Rice P. A., Steitz T. A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 256:1992;1783-1790.
13. Kosalaraksa P., Kavlick M. F., Maroun V., Le R., Mitsuya H. Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay. J. Virol. 73:1999;5356-5363.
14. Kozal M. J., Shah N., Schen N., Yang R., Fucini R., Merigan T. C., Richman D. D., Morris D., Hubbell E., Chee M., Gingeras T. R. Extensive polymorphism observed in HIV-1 clade B protease gene using high density oligonucleotide arrays. Nature Med. 2:1996;753-759.
15. Larder B. A., Bloor S., Kemp S. D., Hertogs K., Desmet R. L., Miller V., Sturmer M., Staszewski S., Ren J., Stammers D. K., Stuart D. I., Powels R. A family of insertion mutations between codons 67 and 70 of human imunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob. Agents Chemother. 43:1999;1961-1967.
16. Maeda Y., Venzon D. J., Mitsuya H. Altered drug sensitivity, fitness, and evolution of HIV-1 with pol gene mutations conferring multi-dideoxynucleoside resistance. J. Infect. Dis. 177:1998;1207-1213.
17. Pathak V. K., Temin H. M. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. USA. 87:1990;6019-6023.
18. Ross L., Johnson M., Graham N., Shaefer M., St Clair M. The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy. J. Hum. Virol. 2:1999;290-295.
19. Sarafanios S. G., Das K., Ding J., Boyer P. L., Hugues S. H., Arnold E. Touching the heart of HIV-1 drug resistance: The fingers close down on the dNTP at the polymerase active site. Chem. Biol. 6:1999;R137-R146.
20. Shirasaka T., Kavlick M. F., Ueno T., Gao W. Y., Kaojima E., Alcaide M. L., Chockekuchai S., Roy B. M., Arnold E., Yarchoan R., Mitsuya H. Emergence of human imunodeficiency virus type 1 varaiants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA. 92:1995;2398-2402.
21. Tamalet C., Izopet J., Koch N., Fantini J., Yahi N. Stable rearrangements of the β3-β4 hairpin loop of HIV-1 reverse transcriptase in plasma viruses from patients receiving combination therapy. AIDS. 12:1998;F161-F166.
22. Tantillo C., Ding J., Jacobo-Molina A., Nanni R. G., Boyer P. L., Hughes S. H., Pauwels R., Andries K., Janssen P. A., Arnold E. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243:1994;369-387.
23. Vahey M., Nau M. E., Barrick S., Cooley J. D., Sawyer R., Leeker A. A., Vickerman P., Bloor S., Larder B., Michael N. L., Wegner S. A. Limitations of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of diverse human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J. Clin. Microbiol. 37:1999;2533-2537.
24. Winters M. A., Coolley K. L., Girard Y. A., Levee D. J., Hamdan H., Shafer R. W., Katzenstein D. A., Merigan T. C. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. J. Clin. Invest. 102:1998;1769-1775.
25. Yahi N., Tamalet C., Tourrès C., Tivoli N., Ariasi F., Volot F., Gastaut J. A., Gallais H., Moreau J., Fantini J. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: Survey of 787 sequences. J. Clin. Microbiol. 37:1999;4099-4106.